
Photo taken from ACS Journal Cancer/X
May 24, 2024, 14:15
ACS Journal Cancer Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at ASCO
ACS Journal Cancer shared the following on X:
“Our Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at this year’s ASCO Plenary Session! ICYMI: Dr. Ramalingam and Ticiana Batista recently authored an editorial on the 20th anniversary of EGFR.”
Source: ACS Journal Cancer/X
>
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 10:45
Feb 21, 2025, 10:07
Feb 21, 2025, 09:58
Feb 21, 2025, 09:54
Feb 21, 2025, 09:45
Feb 21, 2025, 09:35
Feb 21, 2025, 09:18